These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2548130)
1. The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease. Galloway PG; Bergeron C; Perry G Neurosci Lett; 1989 May; 100(1-3):6-10. PubMed ID: 2548130 [TBL] [Abstract][Full Text] [Related]
2. Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. Galloway PG; Grundke-Iqbal I; Iqbal K; Perry G J Neuropathol Exp Neurol; 1988 Nov; 47(6):654-63. PubMed ID: 2459316 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies. Tiller-Borcich JK; Forno LS J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001 [TBL] [Abstract][Full Text] [Related]
4. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. Bancher C; Lassmann H; Budka H; Jellinger K; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM J Neuropathol Exp Neurol; 1989 Jan; 48(1):81-93. PubMed ID: 2462024 [TBL] [Abstract][Full Text] [Related]
5. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Kuljis RO; Martín-Vasallo P; Peress NS Neurosci Lett; 1989 Nov; 106(1-2):49-54. PubMed ID: 2573869 [TBL] [Abstract][Full Text] [Related]
6. Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilament and tau. Pollanen MS; Bergeron C; Weyer L J Neurochem; 1992 May; 58(5):1953-6. PubMed ID: 1373181 [TBL] [Abstract][Full Text] [Related]
7. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Hansen LA; Masliah E; Terry RD; Mirra SS Acta Neuropathol; 1989; 78(2):194-201. PubMed ID: 2546359 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases. Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments. Pollanen MS; Bergeron C; Weyer L Acta Neuropathol; 1994; 88(1):1-6. PubMed ID: 7524261 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease. Fukuda T; Tanaka J; Watabe K; Numoto RT; Minamitani M Acta Pathol Jpn; 1993 Oct; 43(10):545-51. PubMed ID: 8291442 [TBL] [Abstract][Full Text] [Related]
11. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. Brion JP; Couck AM Am J Pathol; 1995 Nov; 147(5):1465-76. PubMed ID: 7485409 [TBL] [Abstract][Full Text] [Related]
12. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions. Iseki E; Takayama N; Furukawa Y; Marui W; Nakai T; Miura S; Uéda K; Kosaka K Neurosci Lett; 2002 Jul; 326(3):211-5. PubMed ID: 12095658 [TBL] [Abstract][Full Text] [Related]
14. Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology. Galloway PG; Perry G Brain Res; 1991 Feb; 541(2):347-9. PubMed ID: 2054646 [TBL] [Abstract][Full Text] [Related]
15. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. Hill WD; Arai M; Cohen JA; Trojanowski JQ J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049 [TBL] [Abstract][Full Text] [Related]
16. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Forno LS; Sternberger LA; Sternberger NH; Strefling AM; Swanson K; Eng LF Neurosci Lett; 1986 Mar; 64(3):253-8. PubMed ID: 2421208 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
18. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Gai WP; Blumbergs PC; Blessing WW Acta Neuropathol; 1996; 91(1):78-81. PubMed ID: 8773150 [TBL] [Abstract][Full Text] [Related]
19. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene. Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014 [TBL] [Abstract][Full Text] [Related]
20. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Kuzuhara S; Mori H; Izumiyama N; Yoshimura M; Ihara Y Acta Neuropathol; 1988; 75(4):345-53. PubMed ID: 3364159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]